Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rafael Holdings Inc (RFL)

Rafael Holdings Inc (RFL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,090
  • Shares Outstanding, K 51,771
  • Annual Sales, $ 920 K
  • Annual Income, $ -30,520 K
  • EBIT $ -32 M
  • EBITDA $ -29 M
  • 60-Month Beta 0.69
  • Price/Sales 66.05
  • Price/Cash Flow N/A
  • Price/Book 0.68

Options Overview Details

View History
  • Implied Volatility 237.58% (+1.62%)
  • Historical Volatility 74.23%
  • IV Percentile 59%
  • IV Rank 15.85%
  • IV High 1,250.29% on 08/13/25
  • IV Low 46.81% on 11/18/25
  • Expected Move (DTE 15) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 668
  • Open Int (30-Day) 669
  • Expected Range 1.1800 to 1.1800

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1200 +5.36%
on 12/31/25
1.6000 -26.25%
on 12/11/25
unch (unch)
since 11/28/25
3-Month
1.1200 +5.36%
on 12/31/25
1.6000 -26.25%
on 12/11/25
-0.1800 (-13.24%)
since 09/30/25
52-Week
1.1200 +5.36%
on 12/31/25
3.1900 -63.01%
on 06/10/25
-0.5500 (-31.79%)
since 12/30/24

Most Recent Stories

More News
Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results

NEWARK, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the first quarter fiscal year 2026 ended October 31, 2025. “We remain pleased...

RFL : 1.1800 (+0.85%)
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

Cyclo Therapeutics’ TransportNPC™ Phase 3 clinical trial for  Trappsol ® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is continuing at the recommendation...

RFL : 1.1800 (+0.85%)
Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors

NEWARK, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) sadly announced today the passing of its Lead Independent Director, Stephen Greenberg, and the...

RFL : 1.1800 (+0.85%)
Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPCâ„¢ Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old

First data on treatment of NPC1 with Trappsol ® Cyclo™ (hydroxypropyl-beta-cyclodextrin) in this age group over a period of 48 weeks At 48 weeks of the sub-study, 7 of 9 patients 1 showed...

RFL : 1.1800 (+0.85%)
Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)

NEWARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) announced today that its subsidiary Cyclo Therapeutics has had two abstracts selected for presentation...

RFL : 1.1800 (+0.85%)
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data

RFL : 1.1800 (+0.85%)
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

RFL : 1.1800 (+0.85%)
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering

RFL : 1.1800 (+0.85%)
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential...

RFL : 1.1800 (+0.85%)
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

RFL : 1.1800 (+0.85%)

Business Summary

Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.

See More

Key Turning Points

3rd Resistance Point 1.2767
2nd Resistance Point 1.2333
1st Resistance Point 1.2067
Last Price 1.1800
1st Support Level 1.1367
2nd Support Level 1.0933
3rd Support Level 1.0667

See More

52-Week High 3.1900
Fibonacci 61.8% 2.3993
Fibonacci 50% 2.1550
Fibonacci 38.2% 1.9107
Last Price 1.1800
52-Week Low 1.1200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar